Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Hummingbird Bioscience

Clinical trials sponsored by Hummingbird Bioscience, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for tough cancers: experimental drug targets HER3 in advanced tumors Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Completed 1

New antibody combo shows promise for Hard-to-Treat cancers

Disease control Completed

This early-phase study tested a new antibody called HMBD-002, given alone or with pembrolizumab, in 48 adults with advanced solid tumors (like lung or breast cancer) that had stopped responding to standard treatments. The main goals were to check safety, find the best dose, and s…

Phase 1 • Sponsor: Hummingbird Bioscience • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC